$2.61T
Total marketcap
$169.03B
Total volume
BTC 50.02%     ETH 15.80%
Dominance

Legend Biotech LEGN Stock

64.66 USD {{ price }} 0.999699% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
11.79B USD
LOW - HIGH [24H]
63.38 - 65.45 USD
VOLUME [24H]
1.27M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.96 USD

Legend Biotech Price Chart

Legend Biotech LEGN Financial and Trading Overview

Legend Biotech stock price 64.66 USD
Previous Close 68.97 USD
Open 68.34 USD
Bid 70.02 USD x 1000
Ask 73.86 USD x 900
Day's Range 68.21 - 72.21 USD
52 Week Range 37.3 - 73.3 USD
Volume 1.03M USD
Avg. Volume 880.92K USD
Market Cap 12.85B USD
Beta (5Y Monthly) -0.051387
PE Ratio (TTM) N/A
EPS (TTM) -2.96 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 82.5 USD

LEGN Valuation Measures

Enterprise Value 10.86B USD
Trailing P/E N/A
Forward P/E -25.537634
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 124.39385
Price/Book (mrq) 18.024284
Enterprise Value/Revenue 105.147
Enterprise Value/EBITDA -21.408

Trading Information

Legend Biotech Stock Price History

Beta (5Y Monthly) -0.051387
52-Week Change 60.54%
S&P500 52-Week Change 19.24%
52 Week High 73.3 USD
52 Week Low 37.3 USD
50-Day Moving Average 64.27 USD
200-Day Moving Average 51.84 USD

LEGN Share Statistics

Avg. Volume (3 month) 880.92K USD
Avg. Daily Volume (10-Days) 968.14K USD
Shares Outstanding 180.35M
Float 71.38M
Short Ratio 7.19
% Held by Insiders 1.41%
% Held by Institutions 39.26%
Shares Short 4.53M
Short % of Float N/A
Short % of Shares Outstanding 2.51%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -500.39%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -28.71%
Return on Equity (ttm) -96.39%

Income Statement

Revenue (ttm) 103.3M USD
Revenue Per Share (ttm) 0.64 USD
Quarterly Revenue Growth (yoy) -12.099%
Gross Profit (ttm) -284006000 USD
EBITDA -507374752 USD
Net Income Avi to Common (ttm) -526160992 USD
Diluted EPS (ttm) -3.23
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 850.12M USD
Total Cash Per Share (mrq) 5.14 USD
Total Debt (mrq) 314.76M USD
Total Debt/Equity (mrq) 48.19 USD
Current Ratio (mrq) 3.843
Book Value Per Share (mrq) 3.953

Cash Flow Statement

Operating Cash Flow (ttm) -263647008 USD
Levered Free Cash Flow (ttm) -286797632 USD

Profile of Legend Biotech

Country United States
State NJ
City Somerset
Address 2101 Cottontail Lane
ZIP 08873
Phone 732 317 5050
Website https://www.legendbiotech.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 1390

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia , gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.

Q&A For Legend Biotech Stock

What is a current LEGN stock price?

Legend Biotech LEGN stock price today per share is 64.66 USD.

How to purchase Legend Biotech stock?

You can buy LEGN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Legend Biotech?

The stock symbol or ticker of Legend Biotech is LEGN.

Which industry does the Legend Biotech company belong to?

The Legend Biotech industry is Biotechnology.

How many shares does Legend Biotech have in circulation?

The max supply of Legend Biotech shares is 182.29M.

What is Legend Biotech Price to Earnings Ratio (PE Ratio)?

Legend Biotech PE Ratio is now.

What was Legend Biotech earnings per share over the trailing 12 months (TTM)?

Legend Biotech EPS is -2.96 USD over the trailing 12 months.

Which sector does the Legend Biotech company belong to?

The Legend Biotech sector is Healthcare.

Legend Biotech LEGN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD